⌘K

Home/Filings/4/0000950170-24-116787

4//SEC Filing

Canner David 4

Accession 0000950170-24-116787

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 7:58 PM ET

Size

5.2 KB

Accession

0000950170-24-116787

Insider Transaction Report

Form 4

Period: 2024-10-21

Inhibikase Therapeutics, Inc.IKT

Director

Transactions

Award
Stock Option (right to buy)
2024-10-21+60,000→ 60,000 total
Exercise: $2.22Exp: 2034-10-21→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]The option shares vest 50% on each of the first two anniversaries of October 21, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0002041173

Filing Metadata

Form type: 4
Filed: Oct 22, 8:00 PM ET
Accepted: Oct 23, 7:58 PM ET
Size: 5.2 KB

View on SEC.gov